tiprankstipranks
Fusen Pharmaceutical Co., Ltd. (HK:1652)
:1652
Hong Kong Market
1652
Fusen Pharmaceutical Co., Ltd.
RESEARCH TOOLSreports
Want to see HK:1652 full AI Analyst Report?

Fusen Pharmaceutical Co., Ltd. (1652) Income Statement

0 Followers

Fusen Pharmaceutical Co., Ltd. Income Statement

Last quarter (Q4 2025), Fusen Pharmaceutical Co., Ltd.'s total revenue was ¥162.08M, a decrease of -29.28% from the same quarter last year. In Q4, Fusen Pharmaceutical Co., Ltd.'s net income was ¥11.35M. See Fusen Pharmaceutical Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 273.37M¥ 326.03M¥ 565.61M¥ 491.76M¥ 385.66M
Gross Profit
¥ 109.79M¥ 162.64M¥ 299.51M¥ 225.02M¥ 211.13M
Operating Expenses
¥ 111.51M¥ 230.15M¥ 279.49M¥ 186.41M¥ 146.65M
Depreciation and Amortization
¥ 34.67M¥ 28.10M¥ 35.80M¥ 34.16M¥ 23.79M
EBITDA
¥ 25.55M¥ -39.07M¥ 18.93M¥ 49.90M¥ 55.82M
Operating Income
¥ -1.72M¥ -67.51M¥ 20.02M¥ 15.74M¥ 52.14M
Other Income/Expenses
¥ -5.88M¥ -122.94M¥ -49.46M¥ -74.75M¥ -28.35M
Pretax Income
¥ -7.60M¥ -190.45M¥ -29.45M¥ -30.99M¥ 23.79M
Net Income
¥ -11.78M¥ -188.78M¥ -36.28M¥ -34.65M¥ 16.64M
Per Share Metrics
Basic EPS
¥ -0.02¥ -0.26¥ -0.05¥ -0.05¥ 0.02
Diluted EPS
¥ -0.02¥ -0.26¥ -0.05¥ -0.05¥ 0.02
Weighted Average Shares Outstanding
 739.32M 739.98M 725.54M 756.07M 769.62M
Weighted Average Shares Outstanding (Diluted)
 739.30M 739.98M 752.06M 756.07M 770.31M
Currency in CNY

Fusen Pharmaceutical Co., Ltd. Earnings and Revenue History